| Income Statement for Calypte Biomedical Corp. (CBMC) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 589 | 547 | 427 | 3,297 | 3,467 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 1,590 | 5,664 | 1,754 | (6,790) | 281 | | Gross Operating Profit | 2,179 | 6,211 | 2,181 | (3,493) | 3,748 | | | Selling/General/Admin Expense | (6,409) | (4,322) | (5,363) | (8,979) | (15,517) | | Research & Development | (1,260) | (1,700) | (2,211) | (2,140) | (1,544) | | EBITDA | (5,490) | 189 | (5,393) | (14,612) | (13,313) | | Depreciation & Amortization | (2,149) | (6,059) | (1,887) | (488) | (6,402) | | EBIT | (7,639) | (5,870) | (7,280) | (15,100) | (19,715) | | Interest Income | - | (8,500) | 1,952 | - | - | | Other Income, Net | (72) | 105 | (335) | (38) | 182 | | Total Income Avail For Interest Expense | (8,033) | (13,748) | (5,663) | (15,138) | (19,533) | | Interest Expense | (235) | - | - | (2,126) | (6,969) | | Pre-Tax Income | (8,268) | (13,748) | (5,663) | (17,264) | (26,502) | | Income Taxes | (2) | (2) | (2) | (2) | (2) | | Minority Interest | - | - | - | - | 90 | | Net Income from Continuing Operations | (8,270) | (13,750) | (5,665) | (17,266) | (26,414) | | Net Income from Discontinued Operations | - | - | (3,098) | - | - | | Net Income from Total Operations | (8,270) | (13,750) | (8,763) | (17,266) | (26,414) | | | Normalized Income | (6,742) | (13,750) | (5,665) | (17,266) | (26,414) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | (1,528) | - | - | - | - | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (8,270) | (13,750) | (8,763) | (17,266) | (26,414) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | 90 | | | Basic EPS from Continuing Operations | -0.03 | -0.07 | -0.03 | -0.11 | -0.47 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | | Basic EPS from Total Operations | -0.03 | -0.07 | -0.05 | -0.11 | -0.47 | | | Diluted EPS from Continuing Operations | -0.03 | -0.07 | -0.03 | -0.11 | -0.47 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | | Diluted EPS from Total Operations | -0.03 | -0.07 | -0.05 | -0.11 | -0.47 | | | |
